chains as the technology that they have in place wasn’t
built to handle varied applications and changing regulations
by U.S. and various international governing bodies. In addition, many companies are trying to fill a resource gap when
it comes to understanding technology needs and regulatory
requirements in order to update systems and solutions accordingly. Depending on size and needs, a pharmaceutical
manufacturer might fill the gap with a team of experts or an
individual, or they might also ask their suppliers for information about new laws and regulation.
Since global companies supply products into different
countries that have varying regulations and slight nuances
in how products should be identified and tracked, their
global suppliers should provide compliance with coding
and marking requirements by country while supporting enhanced traceability.
TRENDS DRIVING PHARMACEUTICAL
MANUFACTURERS TO LOOK HARD AT
THEIR SUPPLY CHAINS
As mentioned above, regulations such as the DQSA make
it imperative that the pharmaceutical industry continue to
stay on top of new technology. With traceability requirements moving from the lot level down to the packaging
level, many pharmaceutical manufacturers will need to update both equipment and processes.
The new requirements to which pharmaceutical companies must adhere involve transaction history requiring communication and visibility
among trading partners. They also require
an enhancement of
Today’s pharma manufacturers know an efficient supply chain is an agile supply chain, one that’s able to handle inventory changes while meeting industry regulations. An agile supply chain takes
work, and getting there begins by determining the best
objectives for meeting both internal and external needs.
Internally speaking, pharmaceutical manufacturers are vested
in getting their products through the supply chain efficiently
to end up in the right customers’ hands. Externally, these companies are tasked with meeting regulations regarding product
authenticity and patient safety as outlined by the FDA’s Drug
Quality and Security Act (DQSA), which calls for enhanced identification and tracking of pharmaceuticals throughout the entire
supply chain. As time passes, future requirements of the DQSA
will continue to put pressure on pharmaceutical manufacturers
to work closely with partners to facilitate the exchange of information down to the package level.
SUPPLY CHAIN OPPORTUNITIES FOR
Pharmaceutical manufacturers are also experiencing
greater demand and opportunities for supply chain agility,
customization and responsiveness, but challenging them is
the need to address ever-evolving regulation requirements
while minimizing costs to remain competitive.
WHAT’S HOLDING PHARMACEUTICAL
It’s time for the pharmaceutical industry to advance their
supply chain capabilities and efficiencies. Some pharmaceutical manufacturers may find that they do not have the infrastructure and systems needed to easily improve their supply
■ By Tim Kearns, National Strategic Account Manager, Pharmaceutical & Medical Devices,
Videojet Technologies Inc.
Strengthen supply chain objectives with the latest printing and coding technologies
The Agile Supply Chain
■ 40 OCTOBER 2014 | PHARMACEUTICAL PROCESSING
■ PHARMPRO. COM
Above: Videojet 6420 Thermal Transfer Printer. Right: Videojet 1650 Continuous Ink Jet Printer